This Senate resolution expresses support for the goals and ideals of "Creutzfeldt-Jakob Disease (CJD) Awareness Day." The resolution describes CJD as a rare, fatal brain disorder in a group called prion diseases. It lists facts from the record about CJD cases, symptoms, rapid progression, and typical time to death. The resolution highlights the importance of prion disease surveillance, postmortem brain tissue examination, and the role of the National Prion Disease Pathology Surveillance Center. It also notes links between prion disease study and research on Alzheimer’s disease and related dementias, and calls attention to the challenges faced by patients, families, and caregivers. The preamble refers to establishing November 12, 2025, as "Creutzfeldt-Jakob Disease (CJD) Awareness Day."
The Senate is expressing formal support for raising awareness about CJD and recognizing the importance of surveillance, research, and caregiver needs. The text documents disease facts and urges attention to monitoring human prion diseases and studying connections with other brain disorders. The resolution notes November 12, 2025 as a proposed awareness day. It does not itself create a program, require funding, or change medical rules in the text provided.
No publicly available information.
Supporters, as reflected in the text, emphasize that CJD is rare and rapidly fatal, that continued surveillance and examination of postmortem brain tissue are critical, and that the National Prion Disease Pathology Surveillance Center plays a unique monitoring role. They note that studying prion diseases could help Alzheimer’s and related-dementia research and that families and caregivers face special burdens due to the disease's rapid progression. The resolution frames raising awareness as a way to address these needs.
No publicly available information.